Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 1 - Number 3

Immune Responses to Fungal Infections and Therapeutic Implications

, 1(3): 189 - 197

M. Altamura, D. Casale, M. Pepe and A. Tafaro


DOI: 10.2174/1568005310101030189




Helicobacter Pylori Infection, Immune Response and Vaccination

, 1(3): 199 - 208

A. Lembo, L. Caradonna, T. Magrone, M. L. Mastronardi, D. Caccavo, E. Jirillo and L.Amati


DOI: 10.2174/1568005310101030199




A New Molecular Target of Insulin Action: Regulating the Pivotal PDK1

, 1(3): 209 - 221

K.L.R. Wick and F. Liu


DOI: 10.2174/1568005310101030209




Potential Role for High and Low Molecular Weight Tissue Transglutaminases in Transforming Mammalian Cell Properties

, 1(3): 223 - 232

A. Mezzogiorno and V. Esposito


DOI: 10.2174/1568005310101030223




Update on Sensitivity to Nonsteroidal Antiinflammatory Drugs

, 1(3): 233 - 240

E. Nettis, M.C. Colanardi, A. Ferrannini and A. Tursi


DOI: 10.2174/1568005310101030233




Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy

, 1(3): 241 - 253

G. Ranieri and G. Gasparini


DOI: 10.2174/1568008013341073




The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children

, 1(3): 255 - 264

Scott A. Rivkees


DOI: 10.2174/1568005310101030255




Protein-Tyrosine Phosphatase 1B (PTP1B): A Novel Therapeutic Target for Type 2 Diabetes Mellitus, Obesity and Related States of Insulin Resistance

, 1(3): 265 - 275

Barry J. Goldstein


DOI: 10.2174/1568005310101030265




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science